Selected research
Industry Research
Cell Technology Service Industry Research Report 2026
Market perspective
The global Cell Technology Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Cell Technology Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Cell Technology Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Cell Technology Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Cell Technology Service include Cellular Technology Limited (CTL), Cell Signaling Technology (CST), STEMCELL Technologies, Lifeline® Cell Technology, Cell Microsystems, Cellular Engineering Technologies (CET), VectorBuilder, TERUMO BCT,INC and SC Core & ACT, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Cell Technology Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Cell Technology Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Cell Technology Service Market by Company
Cellular Technology Limited (CTL)
Cell Signaling Technology (CST)
STEMCELL Technologies
Lifeline® Cell Technology
Cell Microsystems
Cellular Engineering Technologies (CET)
VectorBuilder
TERUMO BCT,INC
SC Core & ACT
Cytosurge AG
Simoon Record Beijing Co.,Ltd
Beijing Viewsolid Biotechnology Co.,Ltd
Cyagen Biosciences(Guangzhou)Lnc
Chengdu Kangjing Biotechnology Co., Ltd
Jiangsu Keygen Biotech Corp.,Ltd
Shanghai OE Biotech Co., Ltd
Berry Genomics
Cell Technology Service Segment by Type
Chondrocyte Transplantation
Immune Cell Storage
Cell Technology Service Segment by Application
Hospital
Research Institutions
Others
Cell Technology Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cell Technology Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cell Technology Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cell Technology Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Cell Technology Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Chondrocyte Transplantation
- Immune Cell Storage
Applications
- Hospital
- Research Institutions
- Others
Companies covered
- Cellular Technology Limited (CTL)
- Cell Signaling Technology (CST)
- STEMCELL Technologies
- Lifeline® Cell Technology
- Cell Microsystems
- Cellular Engineering Technologies (CET)
- VectorBuilder
- TERUMO BCT,INC
- SC Core & ACT
- Cytosurge AG
- Simoon Record Beijing Co.,Ltd
- Beijing Viewsolid Biotechnology Co.,Ltd
- Cyagen Biosciences(Guangzhou)Lnc
- Chengdu Kangjing Biotechnology Co., Ltd
- Jiangsu Keygen Biotech Corp.,Ltd
- Shanghai OE Biotech Co., Ltd
- Berry Genomics
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Cell Technology Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Chondrocyte Transplantation
- 2.2.3 Immune Cell Storage
- 2.3 Cell Technology Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospital
- 2.3.3 Research Institutions
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Cell Technology Service Breakdown Data by Type
- 3.1 Global Cell Technology Service Historic Market Size by Type (2021-2026)
- 3.2 Global Cell Technology Service Forecasted Market Size by Type (2027-2032)
4 Cell Technology Service Breakdown Data by Application
- 4.1 Global Cell Technology Service Historic Market Size by Application (2021-2026)
- 4.2 Global Cell Technology Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Cell Technology Service Market Perspective (2021-2032)
- 5.2 Global Cell Technology Service Growth Trends by Region
- 5.2.1 Global Cell Technology Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Cell Technology Service Historic Market Size by Region (2021-2026)
- 5.2.3 Cell Technology Service Forecasted Market Size by Region (2027-2032)
- 5.3 Cell Technology Service Market Dynamics
- 5.3.1 Cell Technology Service Industry Trends
- 5.3.2 Cell Technology Service Market Drivers
- 5.3.3 Cell Technology Service Market Challenges
- 5.3.4 Cell Technology Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Cell Technology Service Players by Revenue
- 6.1.1 Global Top Cell Technology Service Players by Revenue (2021-2026)
- 6.1.2 Global Cell Technology Service Revenue Market Share by Players (2021-2026)
- 6.2 Global Cell Technology Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Cell Technology Service Head Office and Area Served
- 6.4 Global Cell Technology Service Players, Product Type & Application
- 6.5 Global Cell Technology Service Manufacturers Established Date
- 6.6 Global Cell Technology Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Cell Technology Service Market Size (2021-2032)
- 7.2 North America Cell Technology Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Cell Technology Service Market Size by Country (2021-2026)
- 7.4 North America Cell Technology Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Cell Technology Service Market Size (2021-2032)
- 8.2 Europe Cell Technology Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Cell Technology Service Market Size by Country (2021-2026)
- 8.4 Europe Cell Technology Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Cell Technology Service Market Size (2021-2032)
- 9.2 Asia-Pacific Cell Technology Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Cell Technology Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Cell Technology Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Cell Technology Service Market Size (2021-2032)
- 10.2 South America Cell Technology Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Cell Technology Service Market Size by Country (2021-2026)
- 10.4 South America Cell Technology Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Cell Technology Service Market Size (2021-2032)
- 11.2 Middle East & Africa Cell Technology Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Cell Technology Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Cell Technology Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Cellular Technology Limited (CTL)
- 12.1.1 Cellular Technology Limited (CTL) Company Information
- 12.1.2 Cellular Technology Limited (CTL) Business Overview
- 12.1.3 Cellular Technology Limited (CTL) Revenue in Cell Technology Service Business (2021-2026)
- 12.1.4 Cellular Technology Limited (CTL) Cell Technology Service Product Portfolio
- 12.1.5 Cellular Technology Limited (CTL) Recent Developments
- 12.2 Cell Signaling Technology (CST)
- 12.2.1 Cell Signaling Technology (CST) Company Information
- 12.2.2 Cell Signaling Technology (CST) Business Overview
- 12.2.3 Cell Signaling Technology (CST) Revenue in Cell Technology Service Business (2021-2026)
- 12.2.4 Cell Signaling Technology (CST) Cell Technology Service Product Portfolio
- 12.2.5 Cell Signaling Technology (CST) Recent Developments
- 12.3 STEMCELL Technologies
- 12.3.1 STEMCELL Technologies Company Information
- 12.3.2 STEMCELL Technologies Business Overview
- 12.3.3 STEMCELL Technologies Revenue in Cell Technology Service Business (2021-2026)
- 12.3.4 STEMCELL Technologies Cell Technology Service Product Portfolio
- 12.3.5 STEMCELL Technologies Recent Developments
- 12.4 Lifeline® Cell Technology
- 12.4.1 Lifeline® Cell Technology Company Information
- 12.4.2 Lifeline® Cell Technology Business Overview
- 12.4.3 Lifeline® Cell Technology Revenue in Cell Technology Service Business (2021-2026)
- 12.4.4 Lifeline® Cell Technology Cell Technology Service Product Portfolio
- 12.4.5 Lifeline® Cell Technology Recent Developments
- 12.5 Cell Microsystems
- 12.5.1 Cell Microsystems Company Information
- 12.5.2 Cell Microsystems Business Overview
- 12.5.3 Cell Microsystems Revenue in Cell Technology Service Business (2021-2026)
- 12.5.4 Cell Microsystems Cell Technology Service Product Portfolio
- 12.5.5 Cell Microsystems Recent Developments
- 12.6 Cellular Engineering Technologies (CET)
- 12.6.1 Cellular Engineering Technologies (CET) Company Information
- 12.6.2 Cellular Engineering Technologies (CET) Business Overview
- 12.6.3 Cellular Engineering Technologies (CET) Revenue in Cell Technology Service Business (2021-2026)
- 12.6.4 Cellular Engineering Technologies (CET) Cell Technology Service Product Portfolio
- 12.6.5 Cellular Engineering Technologies (CET) Recent Developments
- 12.7 VectorBuilder
- 12.7.1 VectorBuilder Company Information
- 12.7.2 VectorBuilder Business Overview
- 12.7.3 VectorBuilder Revenue in Cell Technology Service Business (2021-2026)
- 12.7.4 VectorBuilder Cell Technology Service Product Portfolio
- 12.7.5 VectorBuilder Recent Developments
- 12.8 TERUMO BCT,INC
- 12.8.1 TERUMO BCT,INC Company Information
- 12.8.2 TERUMO BCT,INC Business Overview
- 12.8.3 TERUMO BCT,INC Revenue in Cell Technology Service Business (2021-2026)
- 12.8.4 TERUMO BCT,INC Cell Technology Service Product Portfolio
- 12.8.5 TERUMO BCT,INC Recent Developments
- 12.9 SC Core & ACT
- 12.9.1 SC Core & ACT Company Information
- 12.9.2 SC Core & ACT Business Overview
- 12.9.3 SC Core & ACT Revenue in Cell Technology Service Business (2021-2026)
- 12.9.4 SC Core & ACT Cell Technology Service Product Portfolio
- 12.9.5 SC Core & ACT Recent Developments
- 12.10 Cytosurge AG
- 12.10.1 Cytosurge AG Company Information
- 12.10.2 Cytosurge AG Business Overview
- 12.10.3 Cytosurge AG Revenue in Cell Technology Service Business (2021-2026)
- 12.10.4 Cytosurge AG Cell Technology Service Product Portfolio
- 12.10.5 Cytosurge AG Recent Developments
- 12.11 Simoon Record Beijing Co.,Ltd
- 12.11.1 Simoon Record Beijing Co.,Ltd Company Information
- 12.11.2 Simoon Record Beijing Co.,Ltd Business Overview
- 12.11.3 Simoon Record Beijing Co.,Ltd Revenue in Cell Technology Service Business (2021-2026)
- 12.11.4 Simoon Record Beijing Co.,Ltd Cell Technology Service Product Portfolio
- 12.11.5 Simoon Record Beijing Co.,Ltd Recent Developments
- 12.12 Beijing Viewsolid Biotechnology Co.,Ltd
- 12.12.1 Beijing Viewsolid Biotechnology Co.,Ltd Company Information
- 12.12.2 Beijing Viewsolid Biotechnology Co.,Ltd Business Overview
- 12.12.3 Beijing Viewsolid Biotechnology Co.,Ltd Revenue in Cell Technology Service Business (2021-2026)
- 12.12.4 Beijing Viewsolid Biotechnology Co.,Ltd Cell Technology Service Product Portfolio
- 12.12.5 Beijing Viewsolid Biotechnology Co.,Ltd Recent Developments
- 12.13 Cyagen Biosciences(Guangzhou)Lnc
- 12.13.1 Cyagen Biosciences(Guangzhou)Lnc Company Information
- 12.13.2 Cyagen Biosciences(Guangzhou)Lnc Business Overview
- 12.13.3 Cyagen Biosciences(Guangzhou)Lnc Revenue in Cell Technology Service Business (2021-2026)
- 12.13.4 Cyagen Biosciences(Guangzhou)Lnc Cell Technology Service Product Portfolio
- 12.13.5 Cyagen Biosciences(Guangzhou)Lnc Recent Developments
- 12.14 Chengdu Kangjing Biotechnology Co., Ltd
- 12.14.1 Chengdu Kangjing Biotechnology Co., Ltd Company Information
- 12.14.2 Chengdu Kangjing Biotechnology Co., Ltd Business Overview
- 12.14.3 Chengdu Kangjing Biotechnology Co., Ltd Revenue in Cell Technology Service Business (2021-2026)
- 12.14.4 Chengdu Kangjing Biotechnology Co., Ltd Cell Technology Service Product Portfolio
- 12.14.5 Chengdu Kangjing Biotechnology Co., Ltd Recent Developments
- 12.15 Jiangsu Keygen Biotech Corp.,Ltd
- 12.15.1 Jiangsu Keygen Biotech Corp.,Ltd Company Information
- 12.15.2 Jiangsu Keygen Biotech Corp.,Ltd Business Overview
- 12.15.3 Jiangsu Keygen Biotech Corp.,Ltd Revenue in Cell Technology Service Business (2021-2026)
- 12.15.4 Jiangsu Keygen Biotech Corp.,Ltd Cell Technology Service Product Portfolio
- 12.15.5 Jiangsu Keygen Biotech Corp.,Ltd Recent Developments
- 12.16 Shanghai OE Biotech Co., Ltd
- 12.16.1 Shanghai OE Biotech Co., Ltd Company Information
- 12.16.2 Shanghai OE Biotech Co., Ltd Business Overview
- 12.16.3 Shanghai OE Biotech Co., Ltd Revenue in Cell Technology Service Business (2021-2026)
- 12.16.4 Shanghai OE Biotech Co., Ltd Cell Technology Service Product Portfolio
- 12.16.5 Shanghai OE Biotech Co., Ltd Recent Developments
- 12.17 Berry Genomics
- 12.17.1 Berry Genomics Company Information
- 12.17.2 Berry Genomics Business Overview
- 12.17.3 Berry Genomics Revenue in Cell Technology Service Business (2021-2026)
- 12.17.4 Berry Genomics Cell Technology Service Product Portfolio
- 12.17.5 Berry Genomics Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst